<DOC>
	<DOCNO>NCT00088062</DOCNO>
	<brief_summary>The purpose study determine safety tolerability STA-5326 give daily twice daily Crohn 's Disease patient moderate disease .</brief_summary>
	<brief_title>STA-5326 Crohn 's Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Patients 1865 year old Crohn 's Disease 6 month CDAI score 220450 +/ 5ASA , stable dose &gt; 2 week +/ Corticosteroids , less equal 40 mg per day stable dose 2 week +/ Infliximab treatment within 4 week +/ 6Mercaptopurine , stable dose 8 week +/ Antibiotics , stable dose 2 week Patients methotrexate , cyclosporine , experimental drug within 3 month screen Pregnancy , breast feed History total proctocolectomy stoma . Previous ileocolectomy would contraindication study Bowel obstruction Surgical bowel resection within 90 day Total parenteral nutrition ( TPN ) , CYA , tacrolimus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>Crohn 's Disease</keyword>
</DOC>